Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › H. pylori infection

H. pylori infection

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for H. pylori infection

3 trials tracked for H. pylori infection: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 12 citations.

3Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 1 Other / NA 1
  1. Phase 3 Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection Completed · 12 cited
  2. Phase 2 ARJ C13 Urea Breath Test System Completed
  3. N/A Patient-Centered Cancer Prevention In Chinese Americans Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Keverprazan-amoxicillin dual therapy shows non-inferior H. pylori eradication versus esomeprazole-amoxicillin
Infectious Disease RCT
Keverprazan-amoxicillin dual therapy shows non-inferior H. pylori eradication versus esomeprazole-amoxicillin New drug shows promise for treating H. pylori infections
This prospective, multicenter randomized controlled trial in 264 treatment-naive adults with H. pylori infection found that 14-day keverpraz…
A new treatment combination showed higher success rates at clearing H. pylori bacteria compared to a standard medication.
Aug 11, 2026

Questions about H. pylori infection

Is bismuth quadruple therapy effective for treating H. pylori in Peptic Ulcer cases?

Yes. Bismuth quadruple therapy is a recommended first-line treatment for H. pylori in peptic ulcer disease, with eradication rates above 85% in most studies.

Full answer →